|

Oral Nutritional Optimization in Total Joint Arthroplasty

RECRUITINGN/ASponsored by NYU Langone Health
Actively Recruiting
PhaseN/A
SponsorNYU Langone Health
Started2021-07-06
Est. completion2026-12-31
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations2 sites

Summary

The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.

Eligibility

Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patient are current candidates for elective primary total hip and total knee arthroplasty
2. Patients ≥55 years of age but ≤ 95
3. Patients who meet at least one of the following three laboratory criteria for malnutrition:

TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: \<15 mg/dl Transferrin: \<200 mg/dl

Exclusion Criteria:

1. Previous history of septic arthritis
2. Allergy to oral supplementation
3. Inability to consume oral supplementation
4. Protein malabsorption syndromes
5. Eating disorders
6. End stage renal and hepatic disease
7. Revision surgery, non-elective surgery, hemiarthroplasty, and unicompartmental knee arthroplasty

Conditions2

ArthritisOsteoarthritis

Locations2 sites

New York

1 site
NYU Langone Health
New York, New York, 10016
Daniel Waren212-598-6245daniel.waren@nyulangone.org

Pennsylvania

1 site
Rothman Orthopedic Institute
Philadelphia, Pennsylvania, 19107
Alicia Reyes267-339-3627Alicia.Reyes@rothmanortho.com

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.